298 related articles for article (PubMed ID: 35073739)
21. Broad anti-herpesviral activity of α-hydroxytropolones.
Dehghanpir SD; Birkenheuer CH; Yang K; Murelli RP; Morrison LA; Le Grice SFJ; Baines JD
Vet Microbiol; 2018 Feb; 214():125-131. PubMed ID: 29408023
[TBL] [Abstract][Full Text] [Related]
22. Resistance to a Nucleoside Analog Antiviral Drug from More Rapid Extension of Drug-Containing Primers.
Chen H; Lawler JL; Filman DJ; Hogle JM; Coen DM
mBio; 2021 Feb; 12(1):. PubMed ID: 33563814
[TBL] [Abstract][Full Text] [Related]
23. Synergistic inhibition of herpesvirus replication by docosanol and antiviral nucleoside analogs.
Marcelletti JF
Antiviral Res; 2002 Nov; 56(2):153-66. PubMed ID: 12367721
[TBL] [Abstract][Full Text] [Related]
24. The UL12 protein of herpes simplex virus 1 is regulated by tyrosine phosphorylation.
Fujii H; Kato A; Mugitani M; Kashima Y; Oyama M; Kozuka-Hata H; Arii J; Kawaguchi Y
J Virol; 2014 Sep; 88(18):10624-34. PubMed ID: 24991005
[TBL] [Abstract][Full Text] [Related]
25. [Prevention and therapy of herpesvirus infections].
Abb J
Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
[TBL] [Abstract][Full Text] [Related]
26. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
[TBL] [Abstract][Full Text] [Related]
27. In vitro activities of benzimidazole D- and L-ribonucleosides against herpesviruses.
Williams SL; Hartline CB; Kushner NL; Harden EA; Bidanset DJ; Drach JC; Townsend LB; Underwood MR; Biron KK; Kern ER
Antimicrob Agents Chemother; 2003 Jul; 47(7):2186-92. PubMed ID: 12821466
[TBL] [Abstract][Full Text] [Related]
28. Novel targets for the development of anti-herpes compounds.
Greco A; Diaz JJ; Thouvenot D; Morfin F
Infect Disord Drug Targets; 2007 Mar; 7(1):11-8. PubMed ID: 17346207
[TBL] [Abstract][Full Text] [Related]
29. The Anti-Human Immunodeficiency Virus Drug Tenofovir, a Reverse Transcriptase Inhibitor, Also Targets the Herpes Simplex Virus DNA Polymerase.
Andrei G; Gillemot S; Topalis D; Snoeck R
J Infect Dis; 2018 Feb; 217(5):790-801. PubMed ID: 29186456
[TBL] [Abstract][Full Text] [Related]
30. Ginkgolic Acid Inhibits Herpes Simplex Virus Type 1 Skin Infection and Prevents Zosteriform Spread in Mice.
Bhutta MS; Shechter O; Gallo ES; Martin SD; Jones E; Doncel GF; Borenstein R
Viruses; 2021 Jan; 13(1):. PubMed ID: 33435520
[TBL] [Abstract][Full Text] [Related]
31. The UL97 protein kinase of human cytomegalovirus and homologues in other herpesviruses: impact on virus and host.
Michel D; Mertens T
Biochim Biophys Acta; 2004 Mar; 1697(1-2):169-80. PubMed ID: 15023359
[TBL] [Abstract][Full Text] [Related]
32. The effect of gramicidin, a topical contraceptive and antimicrobial agent with anti-HIV activity, against herpes simplex viruses type 1 and 2 in vitro.
Bourinbaiar AS; Coleman CF
Arch Virol; 1997; 142(11):2225-35. PubMed ID: 9672588
[TBL] [Abstract][Full Text] [Related]
33. Herpesvirus DNA polymerase: Structures, functions, and mechanisms.
Coen DM; Lawler JL; Abraham J
Enzymes; 2021; 50():133-178. PubMed ID: 34861935
[TBL] [Abstract][Full Text] [Related]
34. CRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections.
van Diemen FR; Kruse EM; Hooykaas MJ; Bruggeling CE; Schürch AC; van Ham PM; Imhof SM; Nijhuis M; Wiertz EJ; Lebbink RJ
PLoS Pathog; 2016 Jun; 12(6):e1005701. PubMed ID: 27362483
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of herpesvirus replication by a series of 4-oxo-dihydroquinolines with viral polymerase activity.
Hartline CB; Harden EA; Williams-Aziz SL; Kushner NL; Brideau RJ; Kern ER
Antiviral Res; 2005 Feb; 65(2):97-105. PubMed ID: 15708636
[TBL] [Abstract][Full Text] [Related]
36. Inhibitors of nucleotidyltransferase superfamily enzymes suppress herpes simplex virus replication.
Tavis JE; Wang H; Tollefson AE; Ying B; Korom M; Cheng X; Cao F; Davis KL; Wold WS; Morrison LA
Antimicrob Agents Chemother; 2014 Dec; 58(12):7451-61. PubMed ID: 25267681
[TBL] [Abstract][Full Text] [Related]
37. Crystal structure of the herpes simplex virus 1 DNA polymerase.
Liu S; Knafels JD; Chang JS; Waszak GA; Baldwin ET; Deibel MR; Thomsen DR; Homa FL; Wells PA; Tory MC; Poorman RA; Gao H; Qiu X; Seddon AP
J Biol Chem; 2006 Jun; 281(26):18193-200. PubMed ID: 16638752
[TBL] [Abstract][Full Text] [Related]
38. The discovery and development of filociclovir for the prevention and treatment of human cytomegalovirus-related disease.
Hussein ITM; Brooks J; Bowlin TL
Antiviral Res; 2020 Apr; 176():104710. PubMed ID: 31940473
[TBL] [Abstract][Full Text] [Related]
39. Inhibitors of the Histone Methyltransferases EZH2/1 Induce a Potent Antiviral State and Suppress Infection by Diverse Viral Pathogens.
Arbuckle JH; Gardina PJ; Gordon DN; Hickman HD; Yewdell JW; Pierson TC; Myers TG; Kristie TM
mBio; 2017 Aug; 8(4):. PubMed ID: 28811345
[TBL] [Abstract][Full Text] [Related]
40. Discovery of Small-Molecule Inhibitors Targeting the E3 Ubiquitin Ligase Activity of the Herpes Simplex Virus 1 ICP0 Protein Using an
Deschamps T; Waisner H; Dogrammatzis C; Roy A; Chacko S; Perera C; Prisinzano TE; Kalamvoki M
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
